Nucleic amplification testing: Individual verses Minipool, what to choose?
Keywords:
MINIPOOL, ID NATAbstract
SEE FULL TEXTReferences
1. Saiki RK, Gelfand DH, Stoffel S, et al. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239 (1): 488-491.
2. Giachetti C, Linnen JM, Kolk DP, et al. High sensitive multiplex assay for detection of HIV type-1 and hepatitis C virus RNA. J clin Microbiol. 2002;40(7): 2408-2419.
3. Euro survelliance Vol-10 Inc Jan –Mar, 2005.
4. Bhatia R, Weber M, Seifried E: Feasibility & efficacy of routine PCR screening of blood donations for Hepatitis C virus, Hepatitis B virus & HIV-1 in blood bank setting. Lancet 1999; 353(9150): 359-363.
5. Dodd RY, Notan EP: Current prevalence if incidence of infectious disease markers & estimated window period risk in American Red cross blood donor population. Transfusion 2002: 42: 975-9.
6. Mine H et al: High through put screening of 16 million serologically negative blood donors of Hepatitis B, Hepatitis C & HIV virus by NAT with specific & sensitive multiplex reagent in Japan. J virol methods 2003; 112:145-151.
7. W.K Roth et al-International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.Vox Sanguinis(2012)102,82-90.
8. Makroo N, Choudhury N, Jagannathan L, et al. Multicenter evaluation of individual donor NAT for simulataneous detection of HIV-1 , Heapatitis B & C virusesin Indian blood donors. Indian J Med Res. 2008;127,140-147.
9. Chatterjee K, Coshic P et al: Individual Donor NAT for blood safety against HIV-1 and Hepatitits B&C viruses in a tertiary care hospital. Nat Med J India; 25(4) : 207-9.
10. Mison L, Seed CR, Margaritis AR, Hyland C; Australian Red cross Blood services. NAT screening of Australian blood donors for Heaptitis C & HIV-1 RNA: Comparison of two high performance testing staregies. Vox Sang, 2003 Jan;84(1): 11-9.
2. Giachetti C, Linnen JM, Kolk DP, et al. High sensitive multiplex assay for detection of HIV type-1 and hepatitis C virus RNA. J clin Microbiol. 2002;40(7): 2408-2419.
3. Euro survelliance Vol-10 Inc Jan –Mar, 2005.
4. Bhatia R, Weber M, Seifried E: Feasibility & efficacy of routine PCR screening of blood donations for Hepatitis C virus, Hepatitis B virus & HIV-1 in blood bank setting. Lancet 1999; 353(9150): 359-363.
5. Dodd RY, Notan EP: Current prevalence if incidence of infectious disease markers & estimated window period risk in American Red cross blood donor population. Transfusion 2002: 42: 975-9.
6. Mine H et al: High through put screening of 16 million serologically negative blood donors of Hepatitis B, Hepatitis C & HIV virus by NAT with specific & sensitive multiplex reagent in Japan. J virol methods 2003; 112:145-151.
7. W.K Roth et al-International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.Vox Sanguinis(2012)102,82-90.
8. Makroo N, Choudhury N, Jagannathan L, et al. Multicenter evaluation of individual donor NAT for simulataneous detection of HIV-1 , Heapatitis B & C virusesin Indian blood donors. Indian J Med Res. 2008;127,140-147.
9. Chatterjee K, Coshic P et al: Individual Donor NAT for blood safety against HIV-1 and Hepatitits B&C viruses in a tertiary care hospital. Nat Med J India; 25(4) : 207-9.
10. Mison L, Seed CR, Margaritis AR, Hyland C; Australian Red cross Blood services. NAT screening of Australian blood donors for Heaptitis C & HIV-1 RNA: Comparison of two high performance testing staregies. Vox Sang, 2003 Jan;84(1): 11-9.
Downloads
Published
03-10-2016
How to Cite
1.
Sareen R. Nucleic amplification testing: Individual verses Minipool, what to choose?. Ann of Pathol and Lab Med [Internet]. 2016 Oct. 3 [cited 2025 Feb. 6];3(4):L15-16. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm769
Issue
Section
Letter to editor
License
Copyright (c) 2016 Rateesh Sareen
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).